[1]
Agop, S., Sharipova, V., Kashibadze, K., Vashadze, D., Tevdoradze, V., Kolosovich, I., Peev, S., Ligonenko, A., Cojocaru, V. and Bely, A. 2022. The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis. Perioperaciina Medicina. 5, 1 (May 2022), 34–46. DOI:https://doi.org/10.31636/prmd.v5i1.5.